Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China.

Authors:
Fang Y; Mei W; Wang C; Ren X; Hu J and 6 more

Journal:
BMC Endocr Disord

Publication Year: 2024

DOI:
10.1186/s12902-023-01528-7

PMCID:
PMC10759755

PMID:
38166872

Journal Information

Full Title: BMC Endocr Disord

Abbreviation: BMC Endocr Disord

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe research protocol has been approved by the Ethics Committee of Wannan Medical College. This study was based on data from the Health Management Center at the First Affiliated Hospital of Wannan Medical College in Wuhu, China. Since the participants in this study came to the hospital for routine physical examinations, the Medical Ethics Committee of Wannan Medical College approved that the study only needs to obtain the participant’s verbal informed consent. Therefore, this study did not have the participants’ written informed consent. Informed consent has been obtained from the participants. All methods in the current research were conducted by the Declaration of Helsinki guidelines and regulations. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This work was supported by the Teaching Reform and Quality Improvement Plan of the Department of Education of Anhui Province-Teaching Teacher (grant number 2019jxms066); The Teaching Reform and Quality Improvement Plan of the Department of Education of Anhui Province-Teaching Team (grant number 2018jxtd153)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025